Post-Treatment Lung Repair: 2024 Clinical Trial Results on N-Acetylcysteine and Glutathione Efficacy

Title: Post-Treatment Lung Repair: 2024 Clinical Trial Results on N-Acetylcysteine and Glutathione Efficacy

Meta Description: Support post-treatment lung repair with N-Acetylcysteine and Glutathione based on 2024 clinical results. Blue Eyes Biotech provides pharmaceutical-grade ingredients for respiratory recovery.

Article:

The recovery of lung function following cancer treatment is a critical aspect of long-term quality of life for survivors. A 2024 clinical trial

published in the European Respiratory Journal has demonstrated the significant benefits of N-Acetylcysteine (NAC) and reduced glutathione

in promoting lung tissue repair and reducing pulmonary fibrosis in patients who have completed lung cancer treatment. The study showed

that the combination therapy improved forced expiratory volume, reduced oxidative stress markers, and enhanced the regeneration of

alveolar epithelial cells. NAC serves as a precursor to glutathione, the body's master antioxidant, and helps break down mucus while

protecting lung tissue from ongoing oxidative damage. These findings provide a strong scientific foundation for nutritional approaches to

pulmonary rehabilitation after cancer treatment. Blue Eyes Biotech CO., Ltd. enables the translation of these clinical findings into effective

nutraceutical products through our supply of pharmaceutical-grade NAC and glutathione ingredients. Our N-Acetylcysteine meets USP

standards for purity and is available in various particle sizes suitable for different delivery forms. Our reduced glutathione is produced

using a proprietary enzymatic process that ensures high purity and stability. For companies developing lung recovery supplements,

the pharmaceutical-grade quality of these ingredients is essential for both efficacy and safety. Blue Eyes Biotech provides comprehensive

technical documentation, including stability data, compatibility information, and dosage recommendations based on the latest clinical

evidence. Our manufacturing processes adhere to strict cGMP standards, ensuring batch-to-batch consistency and product reliability.

By formulating with our high-quality NAC and glutathione, supplement brands can create evidence-based products that genuinely support

pulmonary rehabilitation, helping lung cancer survivors breathe easier and enjoy better quality of life after treatment. Learn more about our

respiratory health ingredients at www.blueeyes-bio.com.